Since PD-L1 expression is regulated by NF-κB75,76, the deactivation of NF-κB by the combination resulted in the attenuation of PD-L1 expression on CML LSCs. This evidence concerns the gene CD274 and chronic myelogenous leukemia, BCR-ABL1 positive.